Article

Bimanual microincision phaco affords advantages in routine and complicated cataracts

While considered by many to be a technique ahead of its time, the benefits of bimanual microincision phacoemulsification make it a better method of lens removal and an especially advantageous technique to use in complicated and challenging cases, said I. Howard Fine, MD, Eugene, OR, in his delivery of the inaugural Charles D. Kelman Lecture to conclude the ?Spotlight on Cataract Surgery 2005? session during the annual meeting of the American Academy of Ophthalmology.

Chicago-While considered by many to be a technique ahead of its time, the benefits of bimanual microincision phacoemulsification make it a better method of lens removal and an especially advantageous technique to use in complicated and challenging cases, said I. Howard Fine, MD, Eugene, OR, in his delivery of the inaugural Charles D. Kelman Lecture to conclude the “Spotlight on Cataract Surgery 2005” session during the annual meeting of the American Academy of Ophthalmology.

Dr. Fine explained that bimanual microincision phaco not only further reduces incision size, but by separating infusion from aspiration, it provides unique fluidic advantages. In addition, it permits surgeons to switch instruments behind hands, and it has led to the introduction of new microsurgical instruments that can be particularly useful in certain complicated situations.

Dr. Fine illustrated his points using intraoperative videos from a series of challenging cataract cases, including in eyes with high myopia, a posterior subluxated lens, zonular dialysis, or a history of radial keratotomy.

He also demonstrated the benefits of microincision instrumentation for performing intraocular pupilloplasty, intraocular cautery of persistent microhyphema, and for late reopening of a fibrosed capsule or late recentering of an IOL with insertion of a capsular tension ring.

In addition, Dr. Fine presented a case of refractive lens exchange to show why he considers bimanual microincision phacoemulsification to be the least invasive and safest way to perform that surgery.

“Charlie Kelman taught me personally to follow my instincts, teach what I believe is the right thing to do, and to continuously try to improve. Bimanual microincision will not reach its full promise until we have microincision lenses available. Nevertheless, for me it is still like money from home, providing many benefits without disadvantages,” Dr. Fine said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.